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ABSTRACT  Thrombokinase  has  been  isolated  from  bovine  plasma  by  a 
procedure which begins with  the highly purified  product of a  previously de- 
scribed method,  chromatographs  it  on DEAE-cellulose, and  then fractionates 
it  by continuous  flow electrophoresis,  yielding  0.2  mg  per  liter  of oxalated 
plasma. The electrophoretic fraction has shown a single  boundary in the ultra- 
centrifuge; and its esterase activity on toluenesulfonylarginine methyl ester has 
been about the same as that of thrombokinase previously isolated by repeated 
electrophoretic fractionations.  Thrombokinase  is a  euglobulin  with  minimum 
solubility near pH 5.0.  It is most stable within  the pH range  7.5  to 9.5;  but 
there is also a  peak in the stability curve near pH  1.8. A  few micrograms  of 
thrombokinase per milliliter can activate prothrombin in the presence of EDTA. 
A few thousandths of a microgram causes rapid production of thrombin in the 
system:  prothrombin,  thrombokinase,  calcium  chloride,  phosphatide,  "ac- 
celerator."  But,  thrombokinase  has less than  1/175  the proteolytic activity of 
crystallized trypsin. 
Thrombokinase  was  first  isolated  from  bovine  plasma  by a  series  of three 
electrophoretic fractionations  (1).  Later,  it was reported  (2,  3)  that chroma- 
tography  on  DEAE-cellulose  offered  a  less  arduous  means  for  attaining  a 
comparable  specific activity.  However,  it  has  been found  that  the  chroma- 
tographic  preparation  is  not  homogeneous  electrophoretically.  Now,  one 
chromatographic  step  and  one  electrophoretic  step  have  been incorporated 
into  the  procedure  for isolation  of thrombokinase. 
Thrombokinase  so  prepared,  has  about  the  same  esterase  activity  on 
toluenesulfonylarginine  methyl  ester  (TAMe)  as  thrombokinase  prepared 
by the more laborious procedure; and it sediments in the ultracentrifuge with 
a  single,  grossly symmetrical  boundary.  A  few of its outstanding  enzymatic 
and physicochemical properties are herein delineated. 
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EXPERIMENTAL 
Methods and Materials 
COAGULATION  METHODS  AND  MATERIALS  As described  (4). 
ASSAY OF THROMBOKINASE  Working  assay,  as described  (4),  except  that  ino- 
sithin  has been substituted  for Howell's cephalin.  All  assays for activity were 
performed by this method unless otherwise specified. 
INOSITHIN  A commercial preparation of alcohol-insoluble phosphatides derived 
from soybeans (5-11).  Supplied  by Associated Concentrates,  Inc., 57-01  32nd 
Avenue, Woodside, New York. 
ASSAY OF TAMe ESTERASE  Method of Sherry and Troll (12)  with the following 
minor  modifications: A  control  incubation  of TAMe without  added  enzyme 
has given a  small increase in formol titration, which has been subtracted from 
the enzyme tests of the day. Assays with thrombokinase were more consistent, 
and generally a  little higher, when dilutions of thrombokinase were made with 
buffered albumin. 
BUFFERED  ALBUMIN FOR COAGULATION TESTS AND  FOR TAMe ESTERASE  ASSAY  A  1 
per cent solution of crystallized  bovine plasma albumin was dialyzed against saline 
buffered with 0.02 M veronal, pH 7.4  (13)  for at least 3 days. It was then diluted  1 
to  10  with  the  same buffer for coagulation  tests.  For esterase assays it was diluted 
1 to 10 with 0.5 M tris buffer, pH 9.0. In each case, it was used as a diluent for throm- 
bokinase. It was not used as a diluent for trypsin, nor for thrombokinase when it was 
to be tested in direct comparison with trypsin. 
CASEINOLYSIS  Method of Kunitz  (14), with minor modifications. 
CRYSTALLIZED TRYPSIN  Twice  crystallized,  salt-free,  lyophilized.  Supplied  by 
Worthington  Biochemical  Corporation,  Freehold,  New Jersey. 
ESTIMATION OF  PROTEIN  (a)  Method  of Lowry  et  al.  (15),  with  crystallized 
bovine albumin as standard,  for Table I, and with thrombokinase as standard,  for 
Figs. 2, 3, and 5.  (b) By optical densityat 280 m/z, with thrombokinase as standard for 
Fig.  4.  (c) By dry weight.  Thrombokinase, product 8, dried to constant weight in a 
vacuum oven at  107-111 °C, for standardization  of methods a  and  b, above. 
DEAE-CELLULOSE  N,N-Diethylaminoethylcellulose,  Eastman  Organic  Chemi- 
cals, Rochester, New York. Suspension prepared as described  (3). 
BUFFER FOR ULTRACENTRIFUGAL  ANALYSIS  0.18  M NaCI: 0.0066  M Na2HPO,: 
0.0002 M KH2PO4, pH 8.01, r[2  =  0.2. 
0. I  M EDTA  0.930  gin.  dihydrated,  disodium salt of EDTA plus 0. I  M NaOH 
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Method of Isolation 
Chromatography  on  DEAE-cellulose  and  continuous  flow  electrophoresis, 
previously studied in  detail  (1-3),  are now added  to  the method described 
in  1959  (4). 
At one point of that procedure, the precursor of thrombokinase is adsorbed 
on barium sulfate, along with prothrombin. Much of the adsorbed prothrom- 
bin is eluted by 0.1  M phosphate, pH 6.6, and discarded. Then, more protein 
is eluted by 0.4 M phosphate,  pH 6.6.  From this second eluate, protein pre- 
cipitated  by ammonium sulfate  between  0.4  and  0.5  saturation  is  concen- 
trated and allowed to activate "spontaneously" at 4°C.  The activated con- 
centrate is stored at  -23°C.  At this point the yield of protein is now 0.032 
TABLE  I 
LATER  STEPS  IN  THE  PREPARATION  OF  THROMBOKINASE 
FROM  212  LITERS  OF  OXALATED  PLASMA 
Yield of  Yield of  Purification 
Product  Volume  activity  protein  index 
per cent of  per unt of 
ml  product 5  product 5  uctivity/protein 
5.  Activated concentrate  220  100  100  1.0 x 
6.  Redissolved isoelectric  212  76  10.2  7.5  x 
precipitate 
7.  Chromatographic  fraction  101  55  3.2  17.2 x 
8.  Electrophoretic  fraction  49  29  0.89  32.6 x 
x,  the purification  index of product  5  with respect to  plasma.  See text. 
Each  numerical  entry is an average value derived  from at  least three preparations. 
per cent. Because of the difficulty of comparing activated product with inac- 
tive precursor, the yield of clotting factor cannot yet be stated; and the puri- 
fication index at this point is designated as x, where x would be obtained by 
dividing yield of clotting factor by yield of protein.  If the  yield of clotting 
10.000 
factor were  10  per cent,  x  would be  0.03~  -  310.  If the yield were  1  per 
cent, x would be 31. 
Once  thrombokinase is  fully activated,  it  becomes possible  at  each  sub- 
sequent  step  to  determine the yield of activity in  relation  to  product  5,  as 
shown  in  Table  I.  At  the  next  step  the  isoelectric precipitate  contains  76 
per cent of the activity, but only 10.2 per cent of the protein. Among the pro- 
teins removed in the supernate are those which would otherwise be hard  to 
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A  column  19 mm in diameter and about 27 cm high is prepared with a  suspension 
of 6 gm DEAE-cellulose, and operated at 4°C. The redissolved isoelectric precipitate 
from ten batches  (212 liters)  of oxalated plasma  is run into the column at the rate 
of 110 ml per hour and is followed by 260 ml 0.12 M phosphate, pH 8.0, at the same 
rate. The effluent is set aside. Then, 0.40 M phosphate, pH 8.0, is introduced in three 
portions of 40 rnl,  10 ral,  and  100  ml,  respectively; and  the effluent is collected in 
three corresponding fractions.  The last fraction usually contains  the entire yield of 
thrombokinase; and it is stored at  --23°C.  One or two such batches are fractlonated 
electrophoretically. 
To each 100 ml of chromatographic fraction, 233 ral saturated ammonium sulfate 
is added, to reach 0.7 saturation.  The precipitate is collected by centrifugation and 
dissolved in  10 ml. 0.4 M phosphate, pH 8.0. The turbid, amber solution is dialyzed 
for 36 to 41 hours at 4°C against veronal r/2  =  0.02, pH 8.6.  The dialyzed concen- 
trate is transferred to the 30 mm sample vessel of a Spinco model CP continuous flow 
paper electrophoresis cell. The cell is operated in a refrigerator at 5-6°C. The instru- 
ment  settings  are:  reservoir 4.2;  left wick  siphon  8.4;  right  wick  siphon  9.9.  This 
results in  a  "tilt to the left;"  i.e.,  the entire pattern  is  pushed  toward  the cathode 
while migration occurs toward the anode. The sample feed rate scale is set at  1.20 
to deliver about 0.46 ml per hour to the extreme left tab near the top of the curtain. 
The electrolyte is veronal r/2  =  0.02,  pH 8.6;  and it is  stored in tubs within the 
refrigerator.  Care  is  taken to  maintain  constant  temperature;  and  the  tubs  are re- 
plenished with precooled buffer. 
First,  the buffer is allowed to flow for several hours.  Then, the electric current is 
turned  on and  the entire system allowed to stabilize overnight. The next morning, 
the sample is started down the curtain; and the collection of fractions is begun 3 to 4 
hours later. Under these conditions, and with a constant current of 50 ma, the voltage 
is kept within a narrow range, e.g.  780 to 795. In one such run, the three best fractions 
were collected in tubes  19,  20,  and  21  of the set of 32 tubes.  Protein impurities oc- 
curred, in low concentration, on both sides of the peak fractions. 
The three best fractions of a  run,  taken  together,  constitute  the  "electropho- 
retic fraction" of this paper.  Its purification  index is  twice as  high  as  that  of 
the  chromatographic  fraction.  This  difference  is  greater  than  would  have 
been expected from results obtained 2 or 3 years ago, and may reflect a  lower 
quality  of present  chromatographic  fractions. 
The  use  of  a  frozen  working  standard  has  been  helpful  in  comparing 
thrombokinase  activity  of  different  preparations  from  month  to  month; 
and this was the basis for the activity data of Table I. However, the working 
standard has not been sufficiently stable at  -18  to  -23°C  to be dependable 
over a  period  of years.  For  this  purpose  the  TAMe  esterase  assay has  been 
more reliable,  provided that comparisons were made after removal of throm- 
bin;  i.e.,  on products 7 and 8. 
Values for TAMe  esterase  units  per  milligram  of the  present  electropho- 
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in 1960 and since, namely between 296 and 359, but sometimes a little higher. 
If product 5  represents a  yield of clotting factor between  1 and  10 per cent, 
then the value of x in Table  I  is  between 31  and 310,  and  the purification 
index  of product  8  is  between  1,000  and  10,000.  In  recent  preparations, 
product 8 has yielded 0.2 mg per liter of oxalated plasma. 
Enzymatic Tests 
When he introduced the term, thrombokinase, in  1904,  Morawitz remarked 
that  it behaved like an  enzyme in many respects  (16).  Especially since the 
first activation experiments with crystallized trypsin  (17),  it has been antici- 
pated  that  the  activator  of prothrombin  would  be  a  trypsin-like  enzyme. 
However,  reports from this  laboratory  (18,  3)  have indicated that  the pro- 
teolytic activity of thrombokinase would, at most, be slight, whether measured 
by fibrinolysis or by caseinolysis. 
On  the  other  hand,  TAMe  esterase  assays  had  revealed  that  thrombo- 
kinase definitely possessed this enzymatic activity in addition to its prothrom- 
bin-activating property. It then became of interest to inquire what the casein- 
olytic activity might be in relation to the esterase activity. This is shown in 
Fig.  1,  where given  amounts  of enzyme, as  measured by esterase  activity, 
have  been  incubated  with  casein  to  determine  their  proteolytic activity. 
As seen from Fig.  1,  trypsin had more than  7  times as much caseinolytic 
effect as product 6 when both preparations were used at concentrations near 
100 esterase units per ml; and it had more than 25 times as much as product 7. 
The low level of caseinolytic activity remained about the same for product 8. 
Other  tests  disclosed  that  trypsin  had  more than  7  times  as  much esterase 
activity  per  mg  as  product  8.  Hence  trypsin  had  at  least  25  X  7  --  175 
times as much caseinolytic activity per mg as  did  thrombokinase at  step  8. 
The small amount  of proteolytic activity remaining at steps  7 and 8  may 
well reflect a  property of the  thrombokinase molecule. However, it remains 
to be proven that even this is not due to a minute amount of impurity. Mean- 
while it  is  concluded that  the  caseinolytic activity of thrombokinase is  less 
than  }~75  that  of  crystallized  trypsin. 
Stability in Relation to pH 
At  different points  along  the  course  of purification,  brief tests  had  shown 
that  thrombokinase was  most  stable  in  slightly alkaline  solution.  The  con- 
centrate was  allowed  to  activate  at  pH  8.8  (4);  the  redissolved  isoelectrie 
precipitate  was  stored  at  pH  7.7  -  7.8,  chromatography  was  performed 
near pH  8.0  (2),  and  electrophoretic fractionation at  pH  8.6  (1). 
The chromatographic fraction, product 7 of Table I,  was found to be most 
stable near pH 8.0,  but a  second peak of fair stability occurred near pH  1.6. 
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esterase as well as when it was estimated by thrombin production in the work- 
ing assay. 
The electrophoretic fraction, product 8  of Table  I,  showed a  similar pH 
stability pattern. 
Portions of electrophoretic fraction, 0.5  ml each, were mixed with 0.5  ml of 0.4  M 
NaC1, then with enough distilled water plus HC1 or NaOH solution to make the total 
volume 2.0  ml.  The concentration of protein was 0.34  mg/ml; and NaC1 was 0.1 
M. The pH value plotted in Fig.  2 is the glass electrode reading,  (corrected when 
necessary  for sodium ion effect),  of a  sample taken immediately after mixing. The 
mixture was incubated at the specified pH for 2 hours at 37°C.  Then a sample was 
immediately diluted  1/250  in  buffered albumin, which brought the  pH  into the 
range, 7.0 to 7.4. This, or a further dilution was assayed for thrombokinase activity, 
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FIGU~  1.  Low caseinolytic activity of 
thrombokinase as  compared with tryp- 
sin. Each  curve shows the  caseinolysis 
produced by different amounts of enzyme 
preparation. The  amount of added en- 
zyme  is  indicated  in  TAMe  esterase 
units. Steps 6, 7, and 8 refer to Table I. 
in comparison with dilutions made directly from the electrophoretic fraction into 
buffered albumin at the beginning of the experiment, and stored at 5°C. 
The  results  are  shown  in  Fig.  2.  Thrombokinase was  most  stable  between 
pH 7.5 and pH 9.5; but there was again a peak near pH  1.85.  The mixtures 
were cloudy from pH 5.68 down through pH 3.99.  The mixture at pH 2.92 
was quite clear; nevertheless it lost almost all its activity.  All the more acid 
mixtures were clear,  except the one at pH  0.62,  which was again cloudy. 
The peak near pH  1.85  invites further investigation. The experiment has 
been  repeated  several  times.  When  tested,  the  pH  has  usually been  about 
the same at the end of the 2 hour incubation as at the beginning. The same 
general  pattern  appeared  when  thrombokinase  was  only  ~5  as  concen- 
trated,  at  0.014  mg/ml,  and  all  mixtures  were  clear  in  the  gross.  The 
loss of activity near pH 4 was not instantaneous; it was not necessary to pass MILSTONE,  OULIANOFF, AND  MII.~TONE  Characteristics of Thrombokinase  3~z 
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through this range very quickly in order to demonstrate  the greater stability 
near pH  1.8.  And near pH  5, the decrease was slow enough to permit isoelec- 
tric  precipitation to occur for  1 hour at 4-6°C without noticeable loss  of ac- 
tivity. 
The foregoing results,  although unusual,  are  not unique  in every respect. 
Under  special  conditions,  trypsin  shows  a  secondary  rise  in  stability  near 
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F1ouz~  3.  Isoelectrie  precipitation  of thrombokinase.  (a)  Activity recovered  in  pre- 
cipitate.  (b)  Protein left in solution. 
pH  13  (19).  Various degrees of stability in  the region of pH 2 to pH 3 have 
been  reported  for  trypsin  (19),  ribonuelease  (20),  lysozyme  (21),  and  plas- 
minogen  (22,  23). 
Thrombokinase  as Euglobulin 
The  isolectric  precipitation  of  partially  purified  thrombokinase  at  step  6 
apparently depends on  the properties  of thrombokinase, per se; for a  similar 
precipitation  can  be  performed  with  thrombokinase isolated  electrophoret- 322  THE  JOURNAL  OF  GENERAL  I~HYSlOLOGY  •  VOLUME  47  •  I963 
ically  (1).  And  it has often been convenient to use this method to concen- 
trate thrombokinase from electrophoretic fractions. 
For the data of Figs. 3 a and 3 b,  1 ml of electrophoretic fraction was diluted to 3 ml 
with cold distilled  water plus 0.1  M acetic acid in varying proportions. The mixture 
was allowed to stand for 30 minutes in a centrifuge at 4°C, and then centrifuged at 
4°C for 30 minutes. The supernate was decanted; and its pH and protein content 
were determined. The precipitate was dissolved in  1 ml veronal r/2  =  0.02,  pH 
8.6; and its thrombokinase was assayed in comparison with the electrophoretic frac- 
tion. 
Fig. 3 a shows that most thrombokinase was recovered in precipitates formed 
at pH 4.8  to 5.2;  and Fig.  3b  shows that the protein was at its minimum 
solubility between pH  4.9  and  5.2.  Further experiments revealed  that  iso- 
electric precipitation  of thrombokinase would  give fair  yield with  concen- 
tration of sodium chloride as high as 0.05 M. In a series of precipitations with 
acetate buffer, pH 4.8,  the solubility of the protein increased sharply when 
the molarity of the buffer rose above 0.5.  Essentially similar,  though quan- 
titatively different, results were obtained at pH  5.0  to  5.1.  Thus,  thrombo- 
kinase  could  be  precipitated,  or  contrariwise,  "salted  in,"  in  the  manner 
typical of a  euglobulin. 
Ultracentrifugal Patterns 
Thrombokinase,  as  isolated  by  repeated  electrophoretic  fractionations, 
made a  close approach  to electrophoretic homogeneity at pH  8.6  (1).  The 
present electrophoretic fraction gave a  single, grossly symmetrical boundary 
in  the  analytical ultracentrifuge, as  illustrated in  Fig.  4. 
37 ml. of electrophoretic fraction was mixed with 37 ml cold distilled water and 20 
ml 0.1 M  acetic acid, which brought the pH to 4.8 as judged by brom cresol green on 
a spot plate. After 30 minutes at 4°C, the precipitate was collected by centrifugation 
for 30 minutes at 4°C and dissolved in 2.0 ml 0.4 M  phosphate, pH 7.98. The solution 
was dialyzed at 4°C against sodium chloride, I'/2  =  0.18:  phosphate F/2  =  0.02, 
pH 8.0. Ultracentrifugal runs were made with the undiluted solution, and also with 
dilutions of the protein solution in the equilibrated buffer. Temperature, which was 
maintained constant for each run, was 18.6°C during the run of Fig. 4. With throm- 
bokinase varying between 0.20 and 0.82 mg/ml, sedimentation was faster with higher 
concentrations of protein,  which  makes it  necessary  to  consider the  possibility  of 
association-dissociation  phenomena. 
No conclusions with regard to ultracentrifugal homogeneity are yet drawn. 
However,  the  single,  grossly  symmetrical  boundaries  were  observed  re- 
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Action  of  Thrombokinase  in  Presence of EDTA 
Evidence  that  thrombokinase  can  function  without  ionic  calcium  was  pre- 
sented  many  years ago  (13,  24).  Nevertheless,  it was desirable  to  test  throm- 
bokinase  in  the  presence  of EDTA,  because  of the  latter's  capacity  to  form 
unusually  stable  complexes  with  calcium  (25)  and  other  ions  (26).  It  has 
been  used  as  an  anticoagulant  (27-31),  and  the  amount  added  has  been 
FIGURE 4.  Ultracentrifuge  patterns of thrombokinase.  Concentration  of protein 0.82 
per cent. Angle  of phaseplate, 70 °. Photographs at  11,  28, 43,  73, 88,  and  136 minutes 
after rotor reached speed of 59,780 Ra~M. Direction of sedimentation is to the right. 
0.5  to  1.5  mg  of disodium  salt  per  ml  of whole  blood.  The  present  studies 
used  0.01  M EDTA,  or  3.72  mg  of the  dihydrated  disodium  salt  per  ml  of 
prothrombin  activation mixture. 
It was verified that 0.01  M EDTA suppressed  production  of thrombin  in  the  system 
used for the working assay of thrombokinase.  For the  present test,  the mixture con- 
tained : 0.5 ml prothrombin (34 units); 0.1  ml inosithin (100/zg); 0.1  ml "accelerator" 
(containing  3.3  /zl treated  bovine  serum); 0.1  ml buffer or 0.1  ml of  0.1  M EDTA, 324  THE  JOURNAL  OF  GENERAL  PHYSIOLOGy  •  VOLUME  47  •  I963 
0.1  ml of 0.025  M calcium chloride; and 0.1  ml of thrombokinase  (0.003  ~g).  Under 
these conditions the accessory factors were necessary for rapid production of thrombin; 
and EDTA exerted a  profound inhibition.  After  10 minutes of activation, a  sample of 
the control test produced a  test clot in 25 seconds. A  sample from the test with EDTA 
failed  to  clot  fibrinogen  in  1 hour. 
On the other hand, when enough thrombokinase was used to convert prothrombin 
without the help of accessory factors, addition of EDTA did not suppress production 
of thrombin. However, when EDTA was 0.01  M in the activation mixture, it was still 
strong  enough,  after  a  sample was  mixed  with  3  parts  of fibrinogen,  to  retard  co- 
agulation  of  the  fibrinogen  by  thrombin.  This  effect  has  long  been  known  (27). 
In the  present control experiments,  EDTA retarded  the  clotting of fibrinogen  more 
than an equimolar concentration of oxalate and more than  10 times its molar concen- 
tration  of added  sodium  chloride.  Because  of this  retardation,  a  special  empirical 
chart would  have been required  to convert clotting times to NIH units of thrombin. 
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by  the  clotting time,  so  that  a  30  second  clotting 
time would give a  relative thrombin value of 100. 
To avoid this, the results of Fig.  5 are presented in a  form based directly on clotting 
time.  Each test contained:  0.5  ml prothrombin  (300 units);  0.3  ml buffer; 0.1  ml of 
0.1  M EDTA; 0.1  ml of peak electrophoretic fraction of thrombokinase,  (5 to 40 #g), 
diluted  with buffer. 
As  seen  in  Fig.  5,  thrombokinase  activated  prothrombin  in  the  presence  of 
0.01  M EDTA;  and  the  rate  depended  directly  on  the  amount  of  thrombo- 
kinase.  It is  concluded  that  thrombokinase  can function  without  the  help  of 
calcium  ions,  or  of other  ions  which  are  tightly  bound  by EDTA. 
DISCUSSION 
The  thrombokinase  prepared  from  bovine  plasma  in  1951  (13)  had  been 
purified  from  a  barium  sulfate  eluate;  and  almost  all  thrombin  had  been 
removed.  This  made  it  possible  to  outline  basic  relationships. 
At  each  subsequent  occasion,  results  have  been  in  accord  with  the  con- 
clusions  reached  in  1951 : that  the  action  of thrombokinase  was  not  entirely MII~TONI~, OULIANOFF,  AND MILSTONE  Characteristics  of Thrombokinase  3~5 
depenclent on ionic calcium; that platelets or brain lipid functioned as acces- 
sory factors in the production of thrombin; and that it was these accessory 
factors which depended on ionic calcium.  Further studies  (32,  33)  made it 
necessary to take into account the possibility  of an  additional  type of acces- 
sory factor,  that represented by the  accelerator  of bovine  barium  carbon- 
ate-treated  serum  (34-39).  Since  then, a  five  reagent  test system has been 
used: 
Primary factors  Accessory  factors 
Prothrombin, thrombokinase  Ca  ++, phospholipid, accelerator 
With  the  other four reagents  constant,  the  rate  of thrombin production is 
determined by the amount of added thrombokinase; and this is the basis of 
the  working  assay.  As  previously considered  (33),  the accelerator  reagent 
might function as  an  accessory for thrombokinase, or possibly as  a  potential 
source of more thrombokinase. 
Recently,  Marciniak  and  Seegers  (40)  described  their  autoprothrombin 
C;  and they acknowledged that  it may well be  the  same  as  the  thrombo- 
kinase  previously described  at  this  laboratory.  It  is measured in a  similar 
five reagent system and is reported to catalyze activation of prothrombin in 
the presence of citrate. However, they believe it is a  derivative of prothrom- 
bin. 
Esnouf and Williams  (41) have reported that their activated factor X  has 
an esterase activity which is reminiscent of thrombokinase as defined in this 
laboratory.  They further  comment on  the  similarity of purification  proce- 
dures,  behavior  on  DEAE-cellulose,  and  the  observed  autoacfivation. 
Macfarlane  (42) has suggested that factor X  can be activated by Russell's 
viper venom. His results indicate that the active product, with phospholipid 
and factor V,  causes rapid prothrombin conversion. On the basis of studies 
with  deficient  human  plasmas,  Ratnoff  (43)  has  tentatively  considered  a 
series of reactions which ends with the formation of "active plasma thrombo- 
plastin"  by factor X,  platelets,  and factor V. 
The  possibility that factor X  is  identical with  thrombokinase or  its pre- 
cursor requires serious consideration, and careful scrutiny. It may be recalled 
that factor V was once considered to resemble the precursor of thrombokinase 
(18), at the time when factor V was said to give rise to factor VI, which then 
activated  prothrombin  (35).  It  subsequently became  clear,  however,  that 
this was not to be the defining property of factor V  (44). In the case of SPCA 
(factor VII),  there was opportunity for direct cross-testing of materials; and 
Alexander  outlined  the  differences  as  well  as  the  similarities  found  (45). 
Although thrombokinase is defined by its activation of prothrombin, it will 326  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  47  "  t963 
be desirable ultimately to find its equivalent in the clinically oriented system 
of numbered clotting factors. 
Even when all the tests are performed in the same laboratory it is sometimes 
difficult  to  establish the  identity  of factors  defined or measured  in different 
ways.  Microgram  quantities  of  thrombokinase  were  used  in  this  study  to 
activate  prothrombin  in  the  presence  of EDTA.  But  nanogram  (10  -9  gm) 
quantities  were  used  in  the  potentially  less  specific  five  reagent  system.  Is 
it actually  the same factor that is being measured in both systems? 
In an earlier  electrophoretic  analysis of partially  purified  thrombokinase, 
each fraction was assayed  for  thrombokinase in the presence  of oxalate  and 
also in the five reagent  system.  The two assays gave closely  parallel activity 
curves  (46).  The purest preparations  have  been active  in both systems  and 
to  a  parallel  extent.  Accumulating  evidence  indicates  that  a  single  factor, 
thrombokinase, has been isolated,  and has been measured in different ways. 
Much of the technical work was done by Harriet F. Brown, William S. Bartek, and Thomas R. 
Saxton. 
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